Jadenu Contraindications

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Contraindications

JADENU is contraindicated in: patients with estimated creatinine clearance <60 mL/min or serum creatinine >2 times the age-appropriate upper limit of normal (ULN); high risk myelodysplastic syndrome (MDS) patients, any other MDS patient with a life expectancy <1 year and patients with other hematological and non-hematological malignancies who are not expected to benefit from chelation therapy due to the rapid progression of their disease; patients with platelet counts <50 x 10⁹/L; patients with hypersensitivity to the active substance, deferasirox, or to any of the excipients. For a complete listing of excipients, see Description.

deferasirox

Manufacturer:

Novartis

Distributor:

DKSH

Four Star